Drug Free Solution, Inc.
Other OTCTotal Valuation
Drug Free Solution, Inc. carries a market capitalization of 88,891.00, placing it among publicly traded companies globally.
| Market Cap | 88,891.00 |
| Enterprise Value | N/A |
Share Statistics
Drug Free Solution, Inc. currently has 35.94M shares outstanding.
| Shares Outstanding | 35.94M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 9,550.77, and the price-to-book ratio stands at -12.22.
| PE Ratio | N/A |
| PS Ratio | 9,550.77 |
| PB Ratio | -12.22 |
| P/TBV Ratio | -57.41 |
| P/FCF Ratio | -26.83 |
| P/OCF Ratio | -27.28 |
Financial Position
Drug Free Solution, Inc. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -2,824.35 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Drug Free Solution, Inc.'s stock has gained approximately 0.0000025% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.0000025% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Drug Free Solution, Inc. generated 2,101.00 in revenue and converted that into -867,712.00 in net income, yielding earnings per share of -0.01. EBITDA reached -862,274.00, while operating income came in at -867,712.00.
| Revenue | 2,101.00 |
| Gross Profit | 2,101.00 |
| Operating Income | -867,712.00 |
| Pretax Income | -867,712.00 |
| Net Income | -867,712.00 |
| EBITDA | -862,274.00 |
| EBIT | -867,712.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Total book value stands at -1.64M, with working capital of -384,362.00 providing operational flexibility.
| Cash & Cash Equivalents | 7,124.00 |
| Total Debt | N/A |
| Net Debt | -7,124.00 |
| Equity (Book Value) | -1.64M |
| Book Value Per Share | -0.02 |
| Working Capital | -384,362.00 |
Cash Flow
Drug Free Solution, Inc. produced -735,452.00 in operating cash flow over the past twelve months. After subtracting 12,340.00 in capital expenditures, free cash flow totaled -723,112.00 - equivalent to -0.01 per share.
| Operating Cash Flow | -735,452.00 |
| Capital Expenditures | 12,340.00 |
| Free Cash Flow | -723,112.00 |
| FCF Per Share | -0.01 |
Margins
Drug Free Solution, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -41,299.95 and net profit margin of -41,299.95 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -41,299.95 |
| Pretax Margin | -41,299.95 |
| Profit Margin | -41,299.95 |
| EBITDA Margin | -41,041.12 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -3.69 |
| FCF Yield | -3.73 |
Stock Splits
Drug Free Solution, Inc.'s most recent stock split took place on January 9, 2014 with a 1:3 split ratio.
| Last Split Date | 1/9/2014 |
| Split Ratio | 1:3 |
Scores
Drug Free Solution, Inc. posts an Altman Z-Score of -104.46, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -104.46 |